Hester Biosciences Ltd
NSE:HESTERBIO

Watchlist Manager
Hester Biosciences Ltd Logo
Hester Biosciences Ltd
NSE:HESTERBIO
Watchlist
Price: 2 403.9 INR 0.92% Market Closed
Market Cap: 20.4B INR
Have any thoughts about
Hester Biosciences Ltd?
Write Note

Hester Biosciences Ltd
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hester Biosciences Ltd
Long-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Hester Biosciences Ltd
NSE:HESTERBIO
Long-Term Investments
â‚ą354.2m
CAGR 3-Years
124%
CAGR 5-Years
57%
CAGR 10-Years
N/A
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Long-Term Investments
â‚ą92.8m
CAGR 3-Years
-7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Transgene Biotek Ltd
BSE:526139
Long-Term Investments
â‚ą950k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Z
Zenotech Laboratories Ltd
BSE:532039
Long-Term Investments
â‚ą13.9m
CAGR 3-Years
21%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Biocon Ltd
NSE:BIOCON
Long-Term Investments
â‚ą7.5B
CAGR 3-Years
13%
CAGR 5-Years
10%
CAGR 10-Years
28%
Panacea Biotec Ltd
NSE:PANACEABIO
Long-Term Investments
â‚ą192.3m
CAGR 3-Years
95%
CAGR 5-Years
27%
CAGR 10-Years
N/A
No Stocks Found

Hester Biosciences Ltd
Glance View

Market Cap
20.4B INR
Industry
Biotechnology

Hester Biosciences Ltd. is a holding company, which engages in the manufacture and trade of poultry vaccines and animal health products. The company is headquartered in Ahmedabad, Gujarat and currently employs 584 full-time employees. Its segments include Poultry division and Animal division. The company provides over 40 products across poultry vaccines (live and inactivated), animal vaccines (live and inactivated), health products and diagnostics. Its product range includes vaccines, drugs, feed supplements and disinfectants. The company manufactures over two live vaccines for large animals, including Peste des Petits Ruminants (PPR) Live vaccines and Goat Pox Vaccine. Its offerings include Avian, including Live B1, Live LAS, Live R2B, Live M48, Live FP, Gumboro M1, Gumboro I and Gumboro I+; swine fever vaccines, and animal, including PPR Vaccine-Sungri 96 strain and Brucella abortus (S19) calf Vaccine. The company offers services, such as seromonitoring for poultry farms and mastitis prevention programs for cattle farms.

HESTERBIO Intrinsic Value
1 593.33 INR
Overvaluation 34%
Intrinsic Value
Price

See Also

What is Hester Biosciences Ltd's Long-Term Investments?
Long-Term Investments
354.2m INR

Based on the financial report for Sep 30, 2024, Hester Biosciences Ltd's Long-Term Investments amounts to 354.2m INR.

What is Hester Biosciences Ltd's Long-Term Investments growth rate?
Long-Term Investments CAGR 5Y
57%

Over the last year, the Long-Term Investments growth was 6%. The average annual Long-Term Investments growth rates for Hester Biosciences Ltd have been 124% over the past three years , 57% over the past five years .

Back to Top